Saturday, October 23, 2021

Where are the bugs? FDA knocks Indian manufacturer for ‘crude’ microbe testing


India’s Panacea Biotec has had a long history of run-ins with global regulators in the past, including being stripped of its prequalified vaccine status nearly a decade ago. Now, FDA investigators have accused the company of failing to properly identify microbes at one of its plants—questioning the quality of its aseptic manufacturing.

FDA investigators blasted Panacea Biotec’s Himachal Pradesh, India, aseptic manufacturing facility for failing to properly identify and record isolated microbes, including using an “incomplete and crude” visual identification process, according to a warning letter posted online Tuesday.

In one case in 2019, Panacea workers identified just one microbe of a possible 6,360 isolated from one of the facility’s aseptic rooms, the FDA said. The ability to properly identify microbes—preferably down to the genus level, the FDA said—is important, because it can help companies identify possible lines of contamination in their facilities.

Whitepaper

Developing COVID-19 vaccines may not be enough: Turning vaccines into vaccinations

COVID-19 vaccines are being developed at a breakneck pace, but a broken supply chain could derail that momentum. What are the steps needed to help ensure the medical supply chain is up to the task?

“Because your firm lacks microbial identification data from environmental monitoring, you lack basic information needed to evaluate the ongoing state of control of your aseptic manufacturing operations,” the letter stated. 

SPECIAL REPORT: The most significant FDA warning letters of 2019

Panacea responded to the FDA’s Form 483 letter following its inspection, saying it would enhance its identification program to better identify isolated microbes. That response didn’t cut it, the FDA said: The company didn’t pledge to identify microbes down to the genus level. 

The FDA also knocked Panacea for improper waterborne endotoxin testing, including—in one notable example—an incident in which one of the workers timed the test off a wall clock that “had not been properly calibrated,” investigators said.

Panacea said it would change its endotoxin testing regimen, but the FDA said its response didn’t go far enough to adequately review its past testing. 

Panacea also had issues with establishing an environmental monitoring system for its vaccines and sterile injectables, including unclear triggers to investigate non-viable particles in its drug batches. 

RELATED: Panacea Biotec accused of selling expired vaccines

Panacea has had a long, troubled history with global regulators, most notably being dropped from the World Health Organization’s prequalified pentavalent vaccine supplier list back in 2011.

In April 2013, inspectors froze the sale of more than 15,000 vials of one of Panacea’s pentavalent vaccines after discovering that someone had tampered with expiry dates. Panacea claimed it was given permission to make the change, and new labels were pasted on top of old ones so the work could be done while keeping the vaccines refrigerated.



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...